Exhaled Breath Condensate pH Does Not Discriminate Asymptomatic Gastroesophageal Reflux or the Response to Lansoprazole Treatment in Children with Poorly Controlled Asthma

Journal of Allergy and Clinical Immunology: In Practice

Volumn 2, Issue 5, 2014, Pages 579-586.e7

  Fitzpatrick, Anne M ^a,b   Holbrook, Janet T ^c   Wei, Christine Y ^c   Brown, Meredith S ^a   Wise, Robert A ^d   Teague, W Gerald ^e  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center for Developmental Lung Biology   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

ACQ; Airway acidification; Airway inflammation; AQLQ; Asthma; Asthma biomarker; Asthma clinical trial; ASUI; BMI; Children; EBC; EPAC; Exhaled breath condensate; Gastroesophageal reflux; GER; ICS; NOx; SARCA

Indexed keywords

LANSOPRAZOLE; BIOLOGICAL MARKER; NITROGEN OXIDE; PROTON PUMP INHIBITOR;

ACIDIFICATION; ARTICLE; ASTHMA; BODY MASS; CAUCASIAN; CHILD; DRUG EFFICACY; DRUG RESPONSE; ESOPHAGEAL PH MONITORING; ESOPHAGUS PH; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE UTILIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; SCHOOL CHILD; SCORING SYSTEM; ADOLESCENT; BREATH ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; LUNG; LUNG FUNCTION TEST; METABOLISM; PATHOPHYSIOLOGY; PH; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ASTHMA; BIOMARKERS; BREATH TESTS; CHILD; DOUBLE-BLIND METHOD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; LANSOPRAZOLE; LUNG; MALE; NITROGEN OXIDES; PROTON PUMP INHIBITORS; RESPIRATORY FUNCTION TESTS;

EID: 84924937855     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2014.04.006     Document Type: Article

References (37)

1. Effros R.M., Casaburi R., Su J., Dunning M., Torday J., Biller J., et al. The effects of volatile salivary acids and bases on exhaled breath condensate pH. Am J Respir Crit Care Med 2006, 173:386-392.
2. Popov T.A. Human exhaled breath analysis. Ann Allergy Asthma Immunol 2011, 106:451-456. quiz 7.
3. Hoffmeyer F., Raulf-Heimsoth M., Bruning T. Exhaled breath condensate and airway inflammation. Curr Opin Allergy Clin Immunol 2009, 9:16-22.
4. Szefler S.J., Wenzel S., Brown R., Erzurum S.C., Fahy J.V., Hamilton R.G., et al. Asthma outcomes: biomarkers. JAllergy Clin Immunol 2012, 129:S9-23.
5. Carpagnano G.E., Barnes P.J., Francis J., Wilson N., Bush A., Kharitonov S.A. Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?. Chest 2004, 125:2005-2010.
6. Ojoo J.C., Mulrennan S.A., Kastelik J.A., Morice A.H., Redington A.E. Exhaled breath condensate pH and exhaled nitric oxide in allergic asthma and in cystic fibrosis. Thorax 2005, 60:22-26.
7. Kostikas K., Papatheodorou G., Ganas K., Psathakis K., Panagou P., Loukides S. pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 2002, 165:1364-1370.
8. Carraro S., Folesani G., Corradi M., Zanconato S., Gaston B., Baraldi E. Acid-base equilibrium in exhaled breath condensate of allergic asthmatic children. Allergy 2005, 60:476-481.
9. Antus B., Barta I., Kullmann T., Lazar Z., Valyon M., Horvath I., et al. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: a longitudinal study. Am J Respir Crit Care Med 2010, 182:1492-1497.
10. Hunt J.F., Fang K., Malik R., Snyder A., Malhotra N., Platts-Mills T.A., et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000, 161:694-699.
11. Brunetti L., Francavilla R., Tesse R., Strippoli A., Polimeno L., Loforese A., et al. Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis. Pediatr Allergy Immunol 2006, 17:422-427.
12. Nicolaou N.C., Lowe L.A., Murray C.S., Woodcock A., Simpson A., Custovic A. Exhaled breath condensate pH and childhood asthma: unselected birth cohort study. Am J Respir Crit Care Med 2006, 174:254-259.
13. Liu L., Teague W.G., Erzurum S., Fitzpatrick A., Mantri S., Dweik R.A., et al. Determinants of exhaled breath condensate pH in a large population with asthma. Chest 2011, 139:328-336.
14. Tseliou E., Bessa V., Hillas G., Delimpoura V., Papadaki G., Roussos C., et al. Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma. Chest 2010, 138:107-113.
15. Hunt J., Yu Y., Burns J., Gaston B., Ngamtrakulpanit L., Bunyan D., et al. Identification of acid reflux cough using serial assays of exhaled breath condensate pH. Cough 2006, 2:3.
16. Shimizu Y., Dobashi K., Mori M. Exhaled breath marker in asthma patients with gastroesophageal reflux disease. JClin Biochem Nutr 2007, 41:147-153.
17. Shimizu Y., Dobashi K., Zhao J.J., Kawata T., Ono A., Yanagitani N., et al. Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal reflux disease. Respiration 2007, 74:558-564.
18. Holbrook J.T., Wise R.A., Gold B.D., Blake K., Brown E.D., et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012, 307:373-381. Writing Committee for the American Lung Association Asthma Clinical Research Center.
19. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159:179-187.
20. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999, 14:902-907.
21. Juniper E.F., Gruffydd-Jones K., Ward S., Svensson K. Asthma Control Questionnaire in children: validation, measurement properties, interpretation. Eur Respir J 2010, 36:1410-1416.
22. Revicki D.A., Leidy N.K., Brennan-Diemer F., Sorensen S., Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest 1998, 114:998-1007.
23. Juniper E.F., Guyatt G.H., Cox F.M., Ferrie P.J., King D.R. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 1999, 14:32-38.
24. Horvath I., Hunt J., Barnes P.J., Alving K., Antczak A., Baraldi E., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005, 26:523-548.
25. Paget-Brown A.O., Ngamtrakulpanit L., Smith A., Bunyan D., Hom S., Nguyen A., et al. Normative data for pH of exhaled breath condensate. Chest 2006, 129:426-430.
26. Vaughan J., Ngamtrakulpanit L., Pajewski T.N., Turner R., Nguyen T.A., Smith A., et al. Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J 2003, 22:889-894.
27. Fitzpatrick A.M., Brown L.A., Holguin F., Teague W.G., National Institutes of Health/National Heart L, Blood Institute Severe Asthma Research P Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma. JAllergy Clin Immunol 2009, 124:990-996.e1-9.
28. Colletti R.B., Christie D.L., Orenstein S.R. Statement of the North American Society for Pediatric Gastroenterology and Nutrition (NASPGN). Indications for pediatric esophageal pH monitoring. JPediatr Gastroenterol Nutr 1995, 21:253-262.
29. Zeger S.L., Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986, 42:121-130.
30. Fitzpatrick A.M., Teague W.G., Holguin F., Yeh M., Brown L.A., Severe Asthma Research Program Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. JAllergy Clin Immunol 2009, 123:146-152.e8.
31. Gaston B., Kelly R., Urban P., Liu L., Henderson E.M., Doctor A., et al. Buffering airway acid decreases exhaled nitric oxide in asthma. JAllergy Clin Immunol 2006, 118:817-822.
32. Niimi A., Nguyen L.T., Usmani O., Mann B., Chung K.F. Reduced pH and chloride levels in exhaled breath condensate of patients with chronic cough. Thorax 2004, 59:608-612.
33. Fitzpatrick A.M., Teague W.G., Meyers D.A., Peters S.P., Li X., Li H., et al. Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. JAllergy Clin Immunol 2011, 127:382-389.e1-13.
34. Moore W.C., Meyers D.A., Wenzel S.E., Teague W.G., Li H., Li X., et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010, 181:315-323.
35. von Jagwitz M., Pessler F., Akmatov M., Li J., Range U., Vogelberg C. Reduced breath condensate pH in asymptomatic children with prior wheezing as a risk factor for asthma. JAllergy Clin Immunol 2011, 128:50-55.
36. Accordino R., Visentin A., Bordin A., Ferrazzoni S., Marian E., Rizzato F., et al. Long-term repeatability of exhaled breath condensate pH in asthma. Respir Med 2008, 102:377-381.
37. Debley J.S., Ohanian A.S., Spiekerman C.F., Aitken M.L., Hallstrand T.S. Effects of bronchoconstriction, minute ventilation, and deep inspiration on the composition of exhaled breath condensate. Chest 2011, 139:16-22.